Drug Shortage Report for CYTOGAM
| Report ID | 185788 |
| Drug Identification Number | 02231962 |
| Brand name | CYTOGAM |
| Common or Proper name | CYTOMEGALOVIRUS IMMUNE GLOBULIN (HUMAN) |
| Company Name | KI BIOPHARMA LLC |
| Market Status | MARKETED |
| Active Ingredient(s) | CYTOMEGALOVIRUS IMMUNOLOBULIN |
| Strength(s) | 2500MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 50 ML |
| ATC code | J06BB |
| ATC description | IMMUNOGLOBULINS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2023-06-15 |
| Actual start date | |
| Estimated end date | 2024-01-15 |
| Actual end date | 2023-12-07 |
| Shortage status | Resolved |
| Updated date | 2023-12-10 |
| Company comments | Technology Transfer from CSL to Kamada |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3 GERMAY DR, UNIT 4 #1302 WILMINGTON, DELAWARE UNITED STATES 19804 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2023-12-10 | French | Compare |
| v4 | 2023-12-10 | English | Compare |
| v3 | 2023-06-16 | English | Compare |
| v2 | 2023-03-01 | French | Compare |
| v1 | 2023-03-01 | English | Compare |
Showing 1 to 5 of 5